Detection systems and methods of use thereof
Detection systems and methods of use thereof, and, in particular, hyperspectral fluorescence systems and methods for detecting aerosolized viral biologics and/or carcinogenic compounds or elements. The system utilizes, and the method is, a non-invasive, immediate, and non-biohazard byproduct method (with the actual imaging to determination generally occurring in less than 3 seconds) with a throughput of the station in around ten seconds (which is allowing for sanitization of the station before and after each individual is tested).
1 . A walk-through detection system comprising:
a station comprising:
a sampling area through which an aerosolized sample is passed, wherein the aerosolized sample is a breath exhalation from an individual in proximity to the station,
a first opening and a second opening, through which a human walks to enter and exit the sampling area, respectively,
a hyperspectral fluorescent camera configured to measure a fluorescence of components of the aerosolized sample, and
a UV-light emitter in proximity to the station, wherein the UV-light emitter is configured to sterilize the station; and
a processor in communication with the hyperspectral fluorescent camera, wherein the processor is configured to receive information related to the fluorescence from the hyperspectral fluorescent camera,
wherein the walk-through detection system is capable of receiving the aerosolized sample, processing the sample, and sterilizing the sampling areas in less than 10 seconds.
2 . The walk-through detection system of claim 1 , wherein the processor is configured to:
determine, within a near real-time, a spectral signature of a component of the components.
3 . The walk-through detection system of claim 2 , wherein the processor is configured to:
identify, within near real-time, a presence of the component in the aerosolized sample based on the spectral signature, wherein the component is selected from a group consisting of viral biologics, carcinogenic compounds, and elements thereof, and combinations thereof.
4 . The walk-through detection system of claim 1 , wherein the walk-through detection system further comprises:
a laser excitation emitter configured to excite the components of the aerosolized sample in an excitation region.
5 . The walk-through detection system of claim 4 , wherein the laser excitation emitter comprises:
a laser having a wavelength in a range of 200 nm to 1200 nm.
6 . The walk-through detection system of claim 4 , wherein the laser excitation emitter comprises:
a laser having a wavelength in a range of 235 nm to 500 nm.
7 . The walk-through detection system of claim 4 , wherein the laser excitation emitter comprises:
a laser having a wavelength of 405 nm.
8 . The walk-through detection system of claim 4 , wherein the laser excitation emitter is integral with the hyperspectral fluorescent camera.
9 . The walk-through detection system of claim 1 , wherein the UV-light emitter has an illumination wavelength of 222 nm.
10 . The walk-through detection system of claim 1 , wherein the individual is in the station.
11 . The walk-through detection system of claim 10 , wherein the station comprises:
a light configured to indicate to the individual when to enter and when to exit the station.
12 . The walk-through detection system of claim 2 , wherein the component is a viral biologic.
13 . The walk-through detection system of claim 12 , wherein the viral biologic is COVID-19.
14 . The walk-through detection system of any of claim 2 , wherein the near real-time is less than 3 seconds.
15 . The walk-through detection system of claim 1 , wherein the processor is configured to:
harvest the information with additional information measured by the hyperspectral fluorescent camera;
identifying one or more of an emergence or re-emergence of a threat by correlating the information and additional information; wherein the threat comprises one or more of a biological hazard, a virus, a carcinogen, or a disease; and
alert a third party of the one or more of the emergence or re-emergence of the threat.
16 . The walk-through detection system of claim 1 , wherein:
the hyperspectral fluorescent camera is configured to measure the fluorescence of components after an excitation of the aerosolized sample in an excitation region, and
the sampling area and the excitation region overlap.
17 . The walk-through detection system of claim 4 , wherein the laser excitation emitter is integral with the hyperspectral fluorescent camera.